Factors associated with excessive polypharmacy in older people

Archives of Public Health

Volumn 73, Issue 1, 2015, Pages

  Walckiers, Denise ^a   Van der Heyden, Johan ^a   Tafforeau, Jean ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

Aged; Belgium; Elderly; General population; Health interview survey; Multiple medication medicine drug use; Polypharmacy

Indexed keywords

EID: 84946208937     PISSN: 07787367     EISSN: 20493258     Source Type: Journal    
DOI: 10.1186/s13690-015-0095-7     Document Type: Article

References (34)

1. Hovstadius B, Petersson G. Factors Leading to Excessive Polypharmacy. Clin Geriatr Med. 2012;28(2):159-72.
2. Fulton MM, Riley AE. Polypharmacy in the elderly: A literature review. J Am Acad Nurse Pract. 2005;17(4):123-32.
3. WHO Centre for Health Development. A glossary of terms for community health care and services for older persons. World Health Organization editor. WHO/WKC/Tech.Ser./04.2. 2004. Geneva, Switzerland. Ageing and Health Technical Report.
4. Fialova D, Topinkova E, Gambassi G, Finne-Soveri H, Jonsson PV, Carpenter I, et al. Potentially inappropriate medication use among elderly home care patients in Europe. JAMA. 2005;293(11):1348-58.
5. Cannon KT, Choi MM, Zuniga MA. Potentially inappropriate medication use in elderly patients receiving home health care: a retrospective data analysis. Am J Geriatr Pharmacother. 2006;4(2):134-43.
6. Pitruzzella R, Franck J. Médications en institutions pour personnes âgées (Région Wallonne). La Revue de Gériâtrie. 2005;30(1):13-22.
7. Dwyer LL, Han B, Woodwell DA, Rechtsteiner EA. Polypharmacy in nursing home residents in the United States: Results of the 2004 National Nursing Home Survey. Am J Geriatr Pharmacother. 2010;8(1):63-72.
8. Elseviers MM, Vander Stichele RR, Van Bortel L. Drug utilization in Belgian nursing homes: impact of residents' and institutional characteristics. Pharmacoepidem Drug Safe. 2010;19(10):1041-8.
9. Morgan TK, Williamson M, Pirotta M, Stewart K, Myers SP, Barnes J. A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Med J Aust. 2012;196(1):50-3.
10. Onder G, Liperoti R, Fialova D, Topinkova E, Tosato M, Danese P, et al. Polypharmacy in nursing home in Europe: results from the SHELTER study. J Gerontol A Biol Sci Med Sci. 2012;67(6):698-704.
11. OECD, European Commission. A good life in old age? Monitoring and improving quality in long-term care. OECD, editor. 2013. OECD health policy studies.
12. Jyrkka J, Enlund H, Korhonen MJ, Sulkava R, Hartikainen S. Patterns of drug use and factors associated with polypharmacy and excessive polypharmacy in elderly persons: results of the Kuopio 75+ study: a cross-sectional analysis. Drugs Aging. 2009;26(6):493-503.
13. Frutos Bernal E, Martin Corral JC, Galindo Villardon P. Factores asociados a la polifarmacia en poblacion anciana no institucionalizada. Analisis de la submuestra de la Encuesta Nacional de Salud 2006 para personas mayores de Castilla y Leon. Rev Esp Geriatr Gerontol. 2011;46(06):303-6.
14. Demarest S, Van der Heyden J, Charafeddine R, Drieskens S, Gisle L, Tafforeau J. Methodological basics and evolution of the Belgian Health Interview Survey 1997-2008. Arch Public Health. 2013;71:24.
15. Répertoire commenté des médicaments. Centre Belge d'Information Pharmacothérapeutique, editor. 2008.
16. Hovstadius B, Astrand B, Petersson G. Dispensed drugs and multiple medications in the Swedish population: an individual-based register study. BMC Clin Pharmacol. 2009;9:11.
17. Auvray L, Le Fur Ph. Améliorer la mesure de la consommation pharmaceutique: une nouvelle méthode de recueil. Centre de recherche d'étude et de documentation en économie de la santé (CREDES), editor. 2002. Paris.
18. Jorgensen T, Johansson S, Kennerfalk A, Wallander MA, Svardsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother. 2001;35(9):1004-9.
19. Haider SI, Johnell K, Thorslund M, Fastbom J. Analysis of the association between polypharmacy and socioeconomic position among elderly aged =77 years in Sweden. Clin Ther. 2008;30(2):419-27.
20. Boutsen M, Laasman JM, Maron L, Vrancken J. Consommation de médicaments en maison de repos: une analyse longitudinale. Bruxelles: Union Nationale des Mutualités Socialistes; 2013. p. 1-16.
21. Karakaya G, Huyghebaert C, Macken E. Analyse de la consommation de médicaments en maison de repos. Bruxelles: Mutualités Libres; 2014. p. 1-52.
22. Brekke M, Hunskaar S, Straand J. Self-reported drug utilization, health, and lifestyle factors among 70-74 year old community dwelling individuals in Western Norway. The Hordaland Health Study (HUSK). BMC Public Health. 2006;6(1):121.
23. Linjakumpu T, Hartikainen S, Klaukka T, Veijola J, Kivela SL, Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J Clin Epidemiol. 2002;55(8):809-17.
24. De Cock J. Polymédication chez les personnes âgées. Bruxelles: INAMI. Infospot; 2014. p. 1-15.
25. Sica DA. Current concepts of pharmacotherapy in hypertension-ophthalmically administered beta blockers and their cardiopulmonary effects. J Clin Hypertens (Greenwich). 2001;3(3):175-8.
26. Han JA, Frishman WH, Wu SS, Palmiero PM, Petrillo R. Cardiovascular and respiratory considerations with pharmacotherapy of glaucoma and ocular hypertension. Cardiol Rev. 2008;16(2):95-108.
27. Demarest S, Van der Heyden J, Charafeddine R, Tafforeau J, Van OH, Van HG. Socio-economic differences in participation of households in a Belgian national health survey. Eur J Public Health. 2013;23(6):981-5.
28. Célant N, Guillaume S, Rochereau T. Enquête sur la santé et la protection sociale 2012. Paris: IRDES; 2014. p. 1-302. Les rapports de l'IRDES.
29. Pappa E, Kontodimopoulos N, Papadopoulos AA, Tountas Y, Niakas D. Prescribed-drug utilization and polypharmacy in a general population in Greece: association with sociodemographic, health needs, health-services utilization, and lifestyle factors. Eur J Clin Pharmacol. 2011;67(2):185-92.
30. Daban F, Pasarin MI, Rodriguez-Sanz M, Garcia-Altes A, Villalbi J, Zara C, et al. Social determinants of prescribed and non-prescribed medicine use. Int J Equity Health. 2010;9(1):12.
31. Kuijpers MAJ, Van Marum RJ, Egberts ACG, Jansen PAF. The OLDY (OLd people Drugs & dYsregulations) study group. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol. 2008;65(1):130-3.
32. Scottish Government Health and Social Care Directorates. Appropriate prescribing for patients and polypharmacy guidance for review of quality, safe and effective use of long-term medication. 2012. Scottish Government. Government Circulars (SHOW).
33. WeMeRec. Prescribing for Older People. Welsh Medicines Resource Centre Bulletin, editor. 2011. 11-2-2015.
34. Nederlands Huisartsen Genootschap. Multidisciplinaire richtlijn Polyfarmacie bij ouderen, 2012. Utrecht: Nederlands Huisartsen Genootschap; 2012.